XML 39 R27.htm IDEA: XBRL DOCUMENT v3.19.3
Summary of Significant Accounting Policies (Details)
1 Months Ended 3 Months Ended 9 Months Ended
Feb. 28, 2019
USD ($)
$ / shares
shares
Sep. 30, 2019
USD ($)
Patent
Application
$ / shares
shares
Sep. 30, 2018
USD ($)
$ / shares
shares
Sep. 30, 2019
USD ($)
Patent
Application
$ / shares
shares
Sep. 30, 2018
USD ($)
$ / shares
shares
Aug. 31, 2019
USD ($)
Mar. 15, 2019
USD ($)
Dec. 31, 2018
USD ($)
Intangibles [Abstract]                
IPR&D asset | $   $ 1,223,000   $ 1,223,000       $ 41,692
Common Stock Warrants [Abstract]                
Issuance of common stock, shares (in shares) | shares 48,930              
Proceeds from issuance of common stock | $ $ 750,000     $ 750,000 $ 1,229,370      
Warrants issued (in shares) | shares 34,192              
Exercise price of warrants (in dollars per share) | $ / shares $ 9.87              
Net Income (Loss) per Common Share [Abstract]                
Antidilutive impact to EPS (in shares) | shares       1,668,660 638,610      
Numerator [Abstract]                
Basic and diluted net loss | $   $ (5,751,610) $ (711,208) $ (2,820,763) $ (2,016,932)      
Denominator [Abstract]                
Shares used in computing basic net loss per share (in shares) | shares   5,246,829 3,346,237 4,729,153 3,253,085      
Net loss per share, basic and diluted (in dollars per share) | $ / shares   $ (1.10) $ (0.21) $ (0.60) $ (0.62)      
Accounting Standards Adopted [Abstract]                
Right to use asset | $           $ 1,200,000 $ 1,400,000  
Lease liability | $           $ 1,200,000 1,400,000  
U.S. [Member]                
Intellectual Property [Abstract]                
Number of patents held | Patent   4   4        
Number of pending patent applications | Application   6   6        
Foreign [Member]                
Intellectual Property [Abstract]                
Number of patents held | Patent   22   22        
Number of pending patent applications | Application   33   33        
Stock Options to Purchase Common Stock [Member]                
Net Income (Loss) per Common Share [Abstract]                
Antidilutive impact to EPS (in shares) | shares       1,405,902 513,534      
Convertible Promissory Note [Member]                
Net Income (Loss) per Common Share [Abstract]                
Antidilutive impact to EPS (in shares) | shares       0 9,216      
Warrants to Purchase Common Stock [Member]                
Net Income (Loss) per Common Share [Abstract]                
Antidilutive impact to EPS (in shares) | shares       262,758 115,860      
ASU 2016-02 [Member]                
Accounting Standards Adopted [Abstract]                
Right to use asset | $             1,400,000  
Lease liability | $             $ 1,400,000